Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Daniel Vitt, PhD$125.2M
Market Cap • 25/07/20242003
(há 21 anos)
2014
(10 years ago)
NASDAQ
Listagem
New York
Sede • New York66
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IMUXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.